HC Wainwright & Co. Initiates Coverage On Sight Sciences with Buy Rating, Announces Price Target of $14

10/15/2026
Impact: 80
Healthcare

HC Wainwright & Co. has initiated coverage on Sight Sciences (NASDAQ: SGHT) with a Buy rating. The firm has set a price target of $14 for the company's stock.

AI summary, not financial advice

Share: